Biocom - Life Sciences Association of California
Close
Call
Profile
San Diego  |   Los Angeles  |   Washington, DC  |   Tokyo
cONTENT bLOCK
Left
Left
 

Biocom & DPAc Roundtable Lunch

 
When:
Tuesday, May 02 2017 - Tuesday, May 02 2017
11:30 AM - 12:30 PM

Add to Calendar America/Los_Angeles Biocom & DPAc Roundtable Lunch You are invited to join Biocom and GlaxoSmithKline's Discovery Partnerships in Academia (DPAc) for our first Los Angeles Area Partner Day Roundtable lunch! This is a great opportunity to learn about DPAc and their interest as well as engaging with their team! 
 
Biocom false MM/DD/YYYY

Where:
Haworth Los Angeles Showroom
444 S. Flower Street, Suite 4800
Los Angeles, California 90071
Registration Deadline:
Tuesday, May 02 2017
10:00 AM
Register


Biocom will be holding a roundtable discussion with members of GlaxoSmithKline's Discovery Partnerships in Academia (DPAc) on May 2nd  at 11:30am in the Downtown Los Angeles Area.
 

This roundtable will provide a unique opportunity for you to learn more about DPAc as an organization as well as their interests in collaborations and partnerships. This is also a chance for you to build a relationship with the DPAc team of experts, and for them to understand the research that is currently being conducted in the greater Los Angeles Region. Join us there! 

Attendance is FREE. Space is limited and registration is required. 


About DPAc:
DPAc is a new model for developing truly innovative medicines. It is based on creating a true partnership between world-class academics and the industry-leading scientists of GSK.

The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise of GlaxoSmithKline (GSK) to establish truly integrated partnerships that can translate innovative research into medicines that benefit patients.


The academic researcher supplies depth of scientific knowledge, creativity and a novel concept. The DPAc team provides drug discovery and development experience, applied research expertise and the considerable resources of GlaxoSmithKline (GSK) R&D.

 

Planner

Oscar Rodarte
 

Sponsored By: